Education
About Us
Working with TipRanks
Follow Us
TAKEDA PHARMACEUTICAL CO LTD Insider Profile
4 Followers
TAKEDA PHARMACEUTICAL CO LTD, Ten Percent Owner at Ovid Therapeutics, holds 8.78M shares in Ovid Therapeutics (Ticker: OVID), holds 0.00 shares in HilleVax, Inc (Ticker: HLVX), holds 3.76M shares in Phathom Pharmaceuticals (Ticker: PHAT).
TAKEDA PHARMACEUTICAL CO LTD Ovid Therapeutics (OVID)Ten Percent Owner
Ovid Therapeutics (OVID)
Ten Percent Owner
Ranked #15,761 out of 106,487 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+26.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that TAKEDA PHARMACEUTICAL CO LTD holds in companies
Most Profitable Insider Trade
The most profitable trade made by TAKEDA PHARMACEUTICAL CO LTD
TAKEDA PHARMACEUTICAL CO LTD's Trading History
Ovid Therapeutics
Dec 09, 2025
Ten Percent Owner
Uninformative Buy
―
$23.01M
Phathom Pharmaceuticals
Jan 25, 2024
Ten Percent Owner
Informative Sell
30.00M
$42.10M
Theseus Pharmaceuticals
Oct 15, 2021
―
Uninformative Buy
―
$6.56M
Xilio Therapeutics
Oct 26, 2021
Ten Percent Owner
Uninformative Buy
―
$11.59M
Day One Biopharmaceuticals
Dec 09, 2021
Ten Percent Owner
Informative Sell
5.50M
$131.22M
Calithera Bio
―
―
―
―
HilleVax, Inc
Sep 19, 2025
―
Uninformative Sell
13.11M
$0.00
List of latest transactions for each holding click on a transaction to see TAKEDA PHARMACEUTICAL CO LTD's performance on stock
You May Also Like
TAKEDA PHARMACEUTICAL CO LTD insider profile FAQ
What is the percentage of profitable transactions made by TAKEDA PHARMACEUTICAL CO LTD?
The percentage of profitable transactions made by TAKEDA PHARMACEUTICAL CO LTD is 60%.
What is the average return per transaction made by TAKEDA PHARMACEUTICAL CO LTD?
The average return per transaction made by TAKEDA PHARMACEUTICAL CO LTD is 26.70%.
What stocks does TAKEDA PHARMACEUTICAL CO LTD hold?
TAKEDA PHARMACEUTICAL CO LTD holds: OVID, PHAT, THRX, XLO, DAWN, CALA, HLVX stocks.
What was TAKEDA PHARMACEUTICAL CO LTD’s latest transaction?
TAKEDA PHARMACEUTICAL CO LTD latest transaction was an Uninformative Buy of ―.
What was TAKEDA PHARMACEUTICAL CO LTD's most profitable transaction?
TAKEDA PHARMACEUTICAL CO LTD’s most profitable transaction was an Informative Buy of OVID stock on November 22, 2019. The return on the trade was 119.20%.
What is TAKEDA PHARMACEUTICAL CO LTD's role in Ovid Therapeutics?
TAKEDA PHARMACEUTICAL CO LTD's role in Ovid Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.